Clinical Trial Update: Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function] [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating mTOR inhibition and other metabolism-modulating interventions in the elderly, including a rapamycin sub-study with cardiac M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• Rapamycin (Sirolimus) (sirolimus)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Aging | Phase 2 | Status: COMPLETED